Tsai, M-C <br/><br/>
Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience.  [electronic resource] 

 -  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases  Jan 2016 
 - 95.e1-95.e7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1469-0691 
<br/><br/><label>Standard No.: </label>10.1016/j.cmi.2015.05.035  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antiviral Agents--administration & dosage<br/>Drug-Related Side Effects and Adverse Reactions<br/>Female<br/>Glomerular Filtration Rate<br/>Guanine--administration & dosage<br/>Hepatitis B, Chronic--drug therapy<br/>Humans<br/>Kidney Diseases--chemically induced<br/>Kidney Function Tests<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Telbivudine<br/>Tenofovir--administration & dosage<br/>Thymidine--administration & dosage<br/>Treatment Outcome